Vitamin D and prostate cancer.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4899-0949-7_5PMID 7645428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

  2005cited by this paper
• Abnormal level of retinoic acid in prostate cancer tissues.

  1996cited by this paper
• Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis.

  1996cited by this paper
• Induction of transforming growth factor‐β autocrine activity by all‐trans‐retinoic acid and 1α,25‐dihydroxyvitamin D3 in NRP‐152 rat prostatic epithelial cells

  1996cited by this paper
• Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, Iα,25‐dihydroxycholecalciferol, all‐trans retinoic acid, 9‐cis retinoic acid, and phenylacetate

  1996cited by this paper
• Immunohistochemical localization of metallothionein in human prostate cancer.

  1996cited by this paper
• The role of vitamin D in normal prostate growth and differentiation.

  1996cited by this paper
• Regulation of growth, PSA/PAP and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells.

  1996cited by this paper
• Association of prostate cancer with vitamin D receptor gene polymorphism.

  1996cited by this paper
• Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

  1996cited by this paper
• Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.

  1996cited by this paper
• Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.

  1996cited by this paper
• Simian virus 40-, but not human papillomavirus-, transformation of prostatic epithelial cells results in loss of growth-inhibition by 1,25-dihydroxyvitamin D-3.

  1996cited by this paper
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

  1995cited by this paper
• Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.

  1995cited by this paper
• Effect of 1,25-dihydroxyvitamin D3 and diltiazem on tissue calcium in uremic rat.

  1995cited by this paper
• 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.

  1995cited by this paper
• IGF‐Binding proteins in human prostate tumor cells: Expression and regulation by 1,25‐dihydroxyvitamin D3

  1995cited by this paper
• Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men.

  1995cited by this paper
• Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer.

  1995cited by this paper
• Suramin, hydrocortisone, and retinoic acid modify inhibitory effects of 1,25-dihydroxyvitamin D(3) on prostatic epithelial cells.

  1995cited by this paper
• The role of stromal-epithelial interaction in normal and malignant growth.

  1995cited by this paper
• Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.

  1995cited by this paper
• Altered growth-regulation of prostatic epithelial-cells by human papillomavirus-induced transformation.

  1995cited by this paper
• Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Sunlight--can it prevent as well as cause cancer?

  1995cited by this paper
• Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA.

  1994cited by this paper
• Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome.

  1994cited by this paper
• Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.

  1994cited by this paper
• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

  1994cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Cancer statistics, 1994

  1994cited by this paper
• Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume

  1993cited by this paper
• Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity.

  1993cited by this paper
• Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.

  1993cited by this paper
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

  1993cited by this paper
• p53 is mutated in a subset of advanced-stage prostate cancers.

  1993cited by this paper
• Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.

  1993cited by this paper
• Interactions between SV40 large‐tumor antigen and the growth suppressor proteins pRB and p53

  1993cited by this paper
• Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.

  1993cited by this paper
• Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.

  1993cited by this paper
• Vitamin D and prostate cancer: a prediagnostic study with stored sera.

  1993cited by this paper
• Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

  1993cited by this paper
• Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.

  1993cited by this paper
• The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.

  1992cited by this paper
• The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.

  1992cited by this paper
• Retinoids in Cancer Treatment

  1992cited by this paper
• Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis.

  1992cited by this paper
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

  1992cited by this paper
• Carcinoma of the prostate.

  1991cited by this paper
• Physiologic basis of endocrine therapy for prostatic cancer.

  1991cited by this paper
• Can colon cancer incidence and death rates be reduced with calcium and vitamin D?

  1991cited by this paper
• Cloning and expression of cDNA encoding 25‐hydroxyvitamin D3 24‐hydroxylase

  1991cited by this paper
• Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.

  1991cited by this paper
• Steroid receptor profile in human prostate cancer metastases as compared with primary prostatic carcinoma

  1991cited by this paper
• Vitamin D3 receptors: structure and function in transcription.

  1991cited by this paper
• 1,25‐Dihydroxyvitamin D3 receptors and human colon adenocarcinoma

  1991cited by this paper
• Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

  1990cited by this paper
• Vitamin D: a modulator of cell proliferation and differentiation.

  1990cited by this paper
• The steroid receptor superfamily: more excitement predicted for the future.

  1990cited by this paper
• The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.

  1990cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Soft tissue calcification in pediatric patients with end-stage renal disease.

  1990cited by this paper
• Hereditary 1,25-dihydroxyvitamin D resistant rickets: molecular basis and implications for the role of 1,25(OH) 2D3 in normal physiology.

  1990cited by this paper
• The role of vitamin D in bone and intestinal cell differentiation.

  1990cited by this paper
• Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study.

  1989cited by this paper
• Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.

  1989cited by this paper
• Multiple sites of action of the vitamin D endocrine system: FSH stimulation of testis 1,25-dihydroxyvitamin D3 receptors.

  1989cited by this paper
• Possible role for vitamin D in controlling breast cancer cell proliferation.

  1989cited by this paper
• The role of the vitamin D endocrine system in health and disease.

  1989cited by this paper
• Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.

  1989cited by this paper
• Distribution of soltriol [1,25(OH)2-vitamin D3] binding sites in male sex organs of the mouse: an autoradiographic study.

  1989cited by this paper
• Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29).

  1989cited by this paper
• A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.

  1989cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation.

  1988cited by this paper
• Cloning and expression of full-length cDNA encoding human vitamin D receptor.

  1988cited by this paper
• Prostate Cancer: The Magnitude of the Problem in the United States

  1988cited by this paper
• Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone.

  1988cited by this paper
• Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.

  1987cited by this paper
• Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D.

  1986cited by this paper
• 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells.

  1986cited by this paper
• Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis.

  1986cited by this paper
• Evidence for alteration of the vitamin D-endocrine system in obese subjects.

  1985cited by this paper
• Evidence for alteration of the vitamin D-endocrine system in blacks.

  1985cited by this paper
• Familial factors affecting prostatic cancer risk and plasma sex‐steroid levels

  1985cited by this paper
• Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.

  1985cited by this paper
• Estrogen and progestin receptors in human prostatic carcinoma

  1985cited by this paper
• Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D3. Interaction and effects of binding on receptor function.

  1984cited by this paper
• Differential effects of androgens and glucocorticoids on regulation of androgen receptor concentrations and cell growth.

  1984cited by this paper
• Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

  1983cited by this paper
• Possible significance of new target tissues for 1,25-dihydroxyvitamin D3.

  1983cited by this paper
• 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.

  1982cited by this paper
• The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins).

  1982cited by this paper
• The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.

  1981cited by this paper
• 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.

  1981cited by this paper

• Nutritional Status of Vitamin B 12 and Vitamin D : Important Indicators of Cancer Risk

  2019cites this paper
• Metal- and redox homeostasis in prostate cancer with vitamin D3 supplementation.

  2018cites this paper
• Anticancer potential of dietary vitamin D and ascorbic acid: A review

  2017cites this paper
• Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.

  2016cites this paper
• Vitamin D in Prostate Cancer.

  2016cites this paper
• Targeted delivery of vitamin D3-loaded nanoparticles to C6 glioma cell line increased resistance to doxorubicin, epirubicin, and docetaxel in vitro

  2016cites this paper
• Anticancer Effects of Vitamins

  2015cites this paper
• Vitamin D Status: Ready for Guiding Prostate Cancer Diagnosis and Treatment?

  2014cites this paper
• Null Association between Vitamin D and PSA Levels among Black Men in a Vitamin D Supplementation Trial

  2014cites this paper
• Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients

  2014cites this paper
• Therapeutic Efficacy of Genistein-Topotecan Combination Compared to Vitamin D3-Topotecan Combination in LNCaP Prostate Cancer Cells

  2013cites this paper
• Tissue Specimens Are Reduced in Cultured Human Prostate Cancer Cells and Retinol Metabolism and Lecithin:Retinol Acyltransferase Levels

  2013cites this paper
• The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation

  2013cites this paper
• Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

  2013cites this paper
• Vitamin D3 supplementation, low-risk prostate cancer, and health disparities.

  2013cites this paper
• Personalized Medicine: New Perspectives in Cancer Treatments

  2013cites this paper
• SEMINAR ZA LEKARE U PRAKSI SEMINAR FOR PHISICIANS

  2013cites this paper
• Glycosylation of Some Selected Phenols and Vitamins

  2013cites this paper
• Vitamin D Biology

  2012cites this paper
• The role of vitamin D in cancer prevention and treatment.

  2012cites this paper
• Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.

  2012cites this paper
• The human health effects of ozone depletion and interactions with climate change

  2011cites this paper
• Normal vitamin D receptor function with increased expression of 25-hydroxyvitamin D(3)-24-hydroxylase in Corriedale sheep with inherited rickets.

  2011cites this paper
• Anti-inflammatory Activity of Calcitriol in Cancer

  2011cites this paper
• Vitamin-D-Versorgung im Säuglings-, Kindes- und Jugendalter

  2011cites this paper
• The role of vitamin D in cancer prevention and treatment.

  2010cites this paper
• Human benign prostatic hyperplasia heterotransplants as an experimental model.

  2010cites this paper
• Maternal Vitamin D Deficiency Leads to Cardiac Hypertrophy in Rat Offspring

  2010cites this paper
• Vitamin D deficiency: an increasing concern in peripheral arterial disease.

  2010cites this paper
• Basic Aspects of Vitamin D Nutrition

  2010cites this paper
• Palliative Systemtherapie des kastrationsresistenten Prostatakarzinoms

  2009cites this paper
• Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.

  2009cites this paper
• [Palliative systemic therapy of castration-resistant prostate cancer: current developments].

  2009cites this paper
• 1,25(OH)2D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

  2009cites this paper
• 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

  2009cites this paper
• Vitamin D for the prevention and treatment of pancreatic cancer.

  2009cites this paper
• The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

  2008cites this paper
• Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

  2008cites this paper
• Diabetes and the vitamin D connection

  2008cites this paper
• Calcitriol as a Chemopreventive and Therapeutic Agent in Prostate Cancer: Role of Anti‐Inflammatory Activity

  2007cites this paper
• Increased Expression of Corepressors in Aggressive Androgen-Independent Prostate Cancer Cells Results in Loss of 1α,25-Dihydroxyvitamin D3 Responsiveness

  2007cites this paper
• PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3).

  2007cites this paper
• Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer

  2007cites this paper
• Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.

  2007cites this paper
• Clinical trials of natural products as chemopreventive agents for prostate cancer

  2006cites this paper
• Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.

  2006cites this paper
• Resurrection of vitamin D deficiency and rickets.

  2006cites this paper
• Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.

  2006cites this paper
• Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells.

  2006cites this paper
• Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.

  2006cites this paper
• Noncalcemic actions of vitamin D receptor ligands.

  2005cites this paper
• Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.

  2005cites this paper
• Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.

  2005cites this paper
• Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention

  2005cites this paper
• Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer

  2005cites this paper
• Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.

  2005cites this paper
• Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy

  2005cites this paper
• Clinical trials involving vitamin D analogs in prostate cancer.

  2005cites this paper
• Modulation der Skelettwirkung von Calcitriol durch Applikationsroute und durch Parathormon

  2005cites this paper
• The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention.

  2005cites this paper
• Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

  2005cites this paper
• 1α,25‐dihydroxyvitamin D3 induced growth inhibition of PC‐3 prostate cancer cells requires an active transforming growth factor beta signaling pathway

  2004cites this paper
• p27Kip1 Stabilization and G1 Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through Down-regulation of Cyclin E/Cyclin-dependent Kinase 2 and Skp1-Cullin-F-box Protein/Skp2 Ubiquitin Ligase*

  2004cites this paper
• Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation.

  2004cites this paper
• Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase*

  2004cites this paper
• Role of 24‐hydroxylase in vitamin D3 growth response of OVCAR‐3 ovarian cancer cells

  2004cites this paper
• The role of Vitamin D3 metabolism in prostate cancer.

  2004cites this paper
• Role of Vitamin D receptor gene in radiation-induced neoplastic transformation of human breast epithelial cell.

  2003cites this paper
• PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile.

  2003cites this paper
• G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer*

  2003cites this paper
• Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells.

  2003cites this paper
• Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE.

  2003cites this paper
• Vitamin D in preventive medicine: are we ignoring the evidence?

  2003cites this paper
• The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances.

  2003cites this paper
• Vitamin D autocrine system and prostate cancer.

  2003cites this paper
• Principles of Cancer Chemoprevention

  2003cites this paper
• Phase II Study of 1α-Hydroxyvitamin D2 in the Treatment of Advanced Androgen-independent Prostate Cancer

  2003cites this paper
• CHAPTER 7 – Vitamin D Biology

  2003cites this paper
• Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells.

  2002cites this paper
• The prospects of retinoids in the treatment of prostate cancer.

  2002cites this paper
• Apoptosis Induction by 1,25-Dihydroxyvitamin D 3 in Prostate Cancer 1

  2002cites this paper
• Natural Products and Environmental Androgens/Antiandrogens

  2002cites this paper
• Can diet affect prostate cancer?

  2002cites this paper
• Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study.

  2001cites this paper
• Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium

  2001cites this paper
• The role of vitamin D in prostate cancer.

  2001influential citation
• Therapeutic uses of vitamin D analogues.

  2001cites this paper
• Vitamin D: Biology, Actions, and Clinical Implications

  2001cites this paper
• Vitamin D and prostate cancer.

  2001cites this paper
• Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer.

  2001cites this paper
• High fat diet increases the weight of rat ventral prostate

  2001cites this paper
• Vitamin D deficiency and disorders of vitamin D metabolism.

  2000cites this paper
• Editorial/Mini-Review: Vitamin D and Prostate Cancer.

  2000cites this paper
• Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)

  2000cites this paper
• The role of receptors in prostate cancer.

  2000cites this paper
• 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration.

  2000cites this paper
• Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D.

  2000cites this paper
• 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.

  2000cites this paper
• Effects of long-term administration of vitamin D3 analogs to mice.

  2000cites this paper
• A survey of vitamin A and D contents of fortified fluid milk in Ontario.

  2000cites this paper